Haematologica, Vol 92, Issue 5, 690-693 doi:10.3324/haematol.10850
Copyright © 2007 by Ferrata Storti Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frøyland, M.
Right arrow Articles by Bogen, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frøyland, M.
Right arrow Articles by Bogen, B.

Multiple Myeloma

A VH4-34+ myeloma protein with weak autoreactivity

Marianne Frøyland, Keith M. Thompson, Susan J. Thorpe, Surinder S. Sahota, Tobias Gedde-Dahl, Bjarne Bogen

From the Institute of Immunology, University of Oslo and Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway (MF, KMT, BB); National Institute for Biological Standards and Control, Potters Bar, UK (SJT); Cancer Sciences Division, University of Southampton, Southampton, UK (SSS); Section of Hematology, Medical Department, Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway (TGD)

Correspondence: Keith M. Thompson, Institute of Immunology, Rikshospitalet, N-0027 Oslo, Norway. E-mail: keith.thompson{at}medisin.uio.no/ bjarne.bogen{at}medisin.uio.no.

It has been suggested that VH4-34 gene segment expression is counter-selected in multiple myeloma (MM) due to a self-tolerance mechanism. We cloned and sequenced a VH4-34 gene segment from bone marrow mononuclear cells of a stage III MM patient. We show that VH4-34 was expressed by the serum IgA myeloma (M)-protein, as demonstrated by reactivity with the VH4-34 specific 9G4 mAb and mass spectrometry (MS). The M-protein had weak reactivity with nuclei. These results demonstrate that VH4-34 may be expressed in secreted IgA M-protein with weak autoreactivity. Thus, counter-selection of VH4-34 is pronounced but not absolute in MM. Mechanisms of how VH4-34 can occasionally be expressed in MM and clinical implications are discussed.

Key words: VH4-34, myeloma protein, autoreactivity.




This article has been cited by other articles:


Home page
 BloodHome page
E. Arons, T. Suntum, M. Stetler-Stevenson, and R. J. Kreitman
VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy
Blood, November 19, 2009; 114(21): 4687 - 4695.
[Abstract] [Full Text] [PDF]